ALEXANDRIA, Va., June 12 -- United States Patent no. 12,296,012, issued on May 13, was assigned to PFIZER INC. (New York).
"Chimeric antigen receptors targeting FLT3" was invented by Barbra Johnson Sasu (San Francisco), Danielle Elizabeth Dettling (San Francisco), Cesar Adolfo Sommer (San Mateo, Calif.), Yik Andy Yeung (South San Francisco, Calif.) and Moustafa Marc Hamze (Nogent-sur-Marne, France).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are antibodies that specifically bind to Fms-like tyrosine kinase 3 (FLT3), chimeric antigen receptors (CARs) that specifically bind to FLT3, and engineered immune cells expressing such CARs (e.g. FLT3-specific CAR-T cells). The invention also provides ...